Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 3
2005 2
2006 3
2007 6
2008 2
2009 6
2010 4
2011 8
2012 9
2013 7
2014 14
2015 14
2016 10
2017 10
2018 14
2019 24
2020 20
2021 17
2022 17
2023 21
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean chung keun hee (5 results)?
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group. van der Heijde D, et al. Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22. Lancet. 2018. PMID: 30360964 Clinical Trial.
The Reply.
Kwon OC, Hong S, Ghang B, Kim YG, Lee CK, Yoo B. Kwon OC, et al. Among authors: lee ck. Am J Med. 2017 Oct;130(10):e469. doi: 10.1016/j.amjmed.2017.06.030. Am J Med. 2017. PMID: 28927546 No abstract available.
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP; RESOLVE-1 Study Group. Spiera R, et al. Arthritis Rheumatol. 2023 Sep;75(9):1608-1618. doi: 10.1002/art.42510. Epub 2023 Jun 15. Arthritis Rheumatol. 2023. PMID: 37098795 Free article. Clinical Trial.
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Østergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J; COAST-X Study Group. Deodhar A, et al. Lancet. 2020 Jan 4;395(10217):53-64. doi: 10.1016/S0140-6736(19)32971-X. Epub 2019 Dec 5. Lancet. 2020. PMID: 31813637 Clinical Trial.
Role of IL-32 Gamma on Bone Metabolism in Autoimmune Arthritis.
Kwon OC, Kim S, Hong S, Lee CK, Yoo B, Chang EJ, Kim YG. Kwon OC, et al. Among authors: lee ck. Immune Netw. 2018 Jun 9;18(3):e20. doi: 10.4110/in.2018.18.e20. eCollection 2018 Jun. Immune Netw. 2018. PMID: 29984038 Free PMC article. Review.
Statins reduce relapse rate in Takayasu arteritis.
Kwon OC, Oh JS, Park MC, Hong S, Lee CK, Yoo B, Kim YG. Kwon OC, et al. Among authors: lee ck. Int J Cardiol. 2019 Jul 15;287:111-115. doi: 10.1016/j.ijcard.2019.02.046. Epub 2019 Feb 20. Int J Cardiol. 2019. PMID: 30824260
Anaphylaxis to tocilizumab in patients with rheumatic disease.
Nam SH, Lim DH, Heo HM, Oh JS, Kwon HS, Kim TB, Ahn SM, Hong S, Lee CK, Yoo B, Kim YG. Nam SH, et al. Among authors: lee ck. Immunotherapy. 2021 Dec;13(18):1483-1489. doi: 10.2217/imt-2020-0307. Epub 2021 Oct 18. Immunotherapy. 2021. PMID: 34657472 Clinical Trial.
179 results